1.26
-0.01 (-0.79%)
| Penutupan Terdahulu | 1.27 |
| Buka | 1.27 |
| Jumlah Dagangan | 249,326 |
| Purata Dagangan (3B) | 584,275 |
| Modal Pasaran | 58,974,592 |
| Harga / Buku (P/B) | 13.65 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 16 Nov 2026 |
| EPS Cair (TTM) | -0.990 |
| Nisbah Semasa (MRQ) | 1.16 |
| Aliran Tunai Operasi (OCF TTM) | -10.08 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -12.28 M |
| Pulangan Atas Aset (ROA TTM) | -263.81% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | OS Therapies Incorporated | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | -1.13 |
|
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 33.38% |
| % Dimiliki oleh Institusi | 1.38% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Howard Financial Services, Ltd. | 30 Sep 2026 | 248,001 |
| Beacon Pointe Advisors, Llc | 30 Jun 2026 | 62,507 |
| Ingalls & Snyder Llc | 30 Jun 2026 | 36,676 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |